BETA: Please send your feedback!
Celgene
CELG:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2020
—
About
Biotechnology
Founded 1986
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
website
Headquarters
Executives
| Name | Title | Gender |
| Isaac Blech | Founder | Male |
| Mark J. Alles | Chief Executive Officer & Director | Male |
| Sol J. Barer, PhD | Founder | Male |
| Robert J. Hugin, MBA | Executive Chairman | Male |
| Richard Cecil Eversfield Morgan | Founder | Male |
| Peter N. Kellogg, MBA | Chief Financial Officer & Executive Vice President | Male |
| Patrick E. Flanigan, III | Vice President-Investor Relations | Male |
| Joseph S. Camardo, MD | Senior Vice President-Global Medical Affairs | Male |
| Scott Andrew Smith | President & Chief Operating Officer | Male |
| David Stirling | Founder | Male |
| Gerald F. Masoudi | Secretary, Executive VP & General Counsel | Male |
| Rupert Vessey, PhD | President-Research & Early Development | Male |
Mindful Investing Summary
Celgene - Competitors and Related Companies
How Celgene stacks up to its peers in the Biotechnology industry or with competing business segments.
Celgene
CELG:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2020
—
Amgen
AMGN:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2020
—
Biogen
BIIB:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2020
—
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2020
—
Alexion Pharmaceuticals
ALXN:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2020
—
Illumina
ILMN:NAS
Biotechnology
—
LARGE cap
(—)
—
since start of 2020
—